Panel of multiple sclerosis experts provides best practice treatment recommendations for Tysabri
Monday, November 30, 2009 - 10:28
in Health & Medicine
Best-practice recommendations for the selection and management of patients with multiple sclerosis (MS) who may benefit from, or are receiving treatment with TYSABRI® (natalizumab) were published today in a supplement to the medical journal Multiple Sclerosis. The panel provided recommendations focusing on appropriate patient selection and patient management.